Attune Pharmaceuticals
Latest round
- Series B
Last raised
- Jan 2019
Total raised
- $23M
Investors
- 6
About Attune Pharmaceuticals
Founded in 2015 and based in New York, US, Attune Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of novel, orally-administered, and small-molecule therapeutics for the treatment of rare diseases. The company's pipeline includes Hereditary Angioedema (HAE), a rare and potentially life-threatening genetic condition resulting from the over-production of bradykinin caused by a genetic deficiency in C1 inhibitor; Paroxysmal Nocturnal Hemoglobinuria (PNH), an ultra-rare and life-threatening disease resulting from the chronic hemolysis of a patient’s red blood cells (RBCs); and Complement Pathway Inhibition, a part of the innate immune system and is comprised of a group of serum proteins that are activated through sequential protease based steps.
Who invested in Attune Pharmaceuticals
6 investors across 1 round
See all investors in Attune Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 23, 2019
Amount
$23M
Investors
Questions about Attune Pharmaceuticals
Who invested in Attune Pharmaceuticals?
Attune Pharmaceuticals has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Attune Pharmaceuticals raised?
Attune Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Attune Pharmaceuticals last raise money?
Attune Pharmaceuticals's most recent round on record is a Series B, in Jan 2019.
What does Attune Pharmaceuticals do?
Founded in 2015 and based in New York, US, Attune Pharmaceuticals, Inc.
Where is Attune Pharmaceuticals headquartered?
Attune Pharmaceuticals is headquartered in New York, US.
Which VCs invest in companies like Attune Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Attune Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Attune Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.